11:33 AM EST - OpSens Inc. : Today announced it has signed an agreement with Cathmedical Cardiovascular S.A. for the integration of its coronary physiology algorithms into the Picasso system, a next generation hemodynamic system. The integrated systems will initially focus on the Spanish cardiology market where the Picasso has a dominant market share. OpSens Inc.
shares T.OPS are trading down $0.01 at $1.70.
